Illumina Inc., US4523271090

Illumina stock gains 3.62 percent as earnings beat estimates

Published on 09/23/2026 at 16:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Illumina stock closed at USD 247.46 on September 22, 2026, up 3.62 percent. Q2 FY2026 EPS reached USD 1.31, beating estimates by USD 0.08.

Schwarzweiß-Reportagefoto einer Wissenschaftlerin beim Pipettieren im Genomiklabor
Illumina Inc. zeigt US4523271090 in dokumentarischer Schwarzweiß-Reportage einer Wissenschaftlerin beim Pipettieren im Labor, Illustration mit AI erstellt.

Illumina Inc. (US4523271090) closed at USD 247.46 on Nasdaq on September 22, 2026, gaining 3.62 percent from the prior close of USD 238.82. The move leaves the stock close to its 52-week high of USD 250.06 and places the company at a market capitalization of USD 37.366 billion.

Second quarter beats estimates

Illumina reported second-quarter fiscal 2026 earnings of USD 1.31 per share, compared with the consensus estimate of USD 1.23, according to MarketBeat on September 23, 2026. The USD 0.08 beat gives the recent share move a concrete earnings reference rather than relying only on technical momentum.

Revenue for Q2 FY2026 was USD 1.16 billion, while earnings reached USD 207 million and the reported profit margin was 17.86 percent, according to Yahoo Finance on September 23, 2026. MarketBeat said quarterly revenue increased 9.4 percent year over year, making the sales comparison the key operating measure behind the earnings result.

Analyst target reaches USD 260

UBS upgraded Illumina to Buy and raised its price target from USD 135 to USD 260 on September 9, 2026, according to Yahoo Finance. The USD 125 increase is the clearest quantified analyst change in the available coverage and places the new target above the September 22 closing price.

The broader analyst picture is more cautious. MarketBeat reported a consensus Hold rating and an average target of USD 199.13 on September 23, 2026, which was 19.5 percent below the USD 247.46 closing price. That gap means the stock's earnings beat and UBS upgrade are being weighed against a valuation already well above the published consensus target.

Stock remains near yearly high

Illumina's September 22 closing price was 88.67 percent above its 2026 starting level of USD 131.16, according to MarketBeat. The 52-week range of USD 88.00 to USD 250.06 shows that the stock was trading only USD 2.60 below its annual high at the latest completed close.

Yahoo Finance listed volume at 2,620,880 shares on September 22, 2026, against an average volume of 2,509,347 shares. The next estimated earnings date shown by Yahoo Finance and MarketBeat is October 29, 2026.

Illumina stock closes near high

Illumina stock closed at USD 247.46 on Nasdaq on September 22, 2026, up 3.62 percent on the session and below the 52-week high of USD 250.06. The latest market capitalization was USD 37.366 billion.

Illumina stock at a glance

  • Company: Illumina Inc.
  • ISIN: US4523271090
  • Ticker: ILMN
  • Trading venue: Nasdaq
  • Price as of September 22, 2026: USD 247.46
  • Market capitalization: USD 37.366 billion as of September 22, 2026
  • Sector / Industry: Healthcare / Diagnostics and Research
  • Next earnings date: October 29, 2026

More news and analyses on Illumina stock

Disclaimer...

en | US4523271090 | ILLUMINA INC. | boerse | 70168051 | bgmi